THE MASTOMYS GASTRIC CARCINOID - ASPECTS OF ENTEROCHROMAFFIN-LIKE CELL-FUNCTION

Citation
Im. Modlin et al., THE MASTOMYS GASTRIC CARCINOID - ASPECTS OF ENTEROCHROMAFFIN-LIKE CELL-FUNCTION, Digestion, 55, 1994, pp. 31-37
Citations number
31
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
ISSN journal
00122823
Volume
55
Year of publication
1994
Supplement
3
Pages
31 - 37
Database
ISI
SICI code
0012-2823(1994)55:<31:TMGC-A>2.0.ZU;2-0
Abstract
The mastomys rodent exhibits a genetic propensity to develop gastric c arcinoid tumors. Utilizing acid inhibitory pharmacotherapy (histamine- 2 receptor antagonists and proton pump inhibitors), we have demonstrat ed transformation from normal to neoplastic enterochromaffin-like (ECL ) cells in a well-defined fashion over a period of 4 months. In additi on, we have demonstrated inhibition of tumor growth with either somato statin or histamine-1 receptor antagonists (terfenadine and cyprohepta dine). In order to define the regulation of growth and secretion of tr ansformed ECL cells, we developed an isolated pure ECL cell system. EC L cells secrete histamine in response to gastrinergic (gastrin), musca rinic (carbachol), and a-adrenergic (isoproterenol) stimulation. Both cAMP and intracellular calcium-dependent mechanisms are involved in th e process of histamine secretion.